Research Finds That Nanoformulated CBD Is Effective For Skin Conditions
Skin conditions, such as acne, psoriasis, and eczema, affect millions of people worldwide. International researchers estimate that over 125 million people suffer from just eczema alone, with roughly 30% of those eczema sufferers eventually developing psoriatic arthritis.
A team of researchers affiliated with various academic universities in India and Australia recently examined the efficacy of nanoformulated cannabidiol as a treatment for serious skin conditions and wound care. Their findings were published in the European Journal of Pharmaceutics and Biopharmaceutics.
“Cannabidiol (CBD), a non-psychoactive chemical derived from Cannabis sativa L., has significant dermatological potential due to its antinflammatory, antioxidant, and wound healing attributes.” the researchers wrote. “However, its clinical usage is limited by instability, minimal skin penetration, and poor solubility.”
“Nanotechnology-based delivery systems such as pickering emulsions, cryogels, lipid nanoparticles, and nanomicelles have emerged as promising strategies to enhance localized skin delivery, improve penetration, enable sustained release, and reduce adverse effects.” they also wrote.
“According to this analysis of 16 papers and 18 patents (2019-2024), CBD that has been nanoformulated offers improved tolerability, sustained release, and skin delivery. According to GRADE review, impacts on dermal absorption, inflammation, and wound healing demonstrated intermediate certainty, but outcomes such as skin penetration, controlled release, and safety showed high certainty.” the researchers found.
“Applications for acne, psoriasis, and eczema show enhanced patient compliance and efficacy. Despite clinical and regulatory obstacles, nano-CBD platforms provide a safe, focused, and efficient approach to improving dermatological care.” the researchers concluded.
A recent market analysis by The Business Research Company estimated that the global cannabis cosmetics market will grow “from $5.48 billion in 2024 to a projected total of $7.29 billion in 2025 at an impressive compound annual growth rate CAGR of 32.8%.”